Showing results (441-450 of 512) with videos related to
Sort By:
Pageof 52
Journal of Crohn'S & Colitis|September 2, 2025
Faecal loss of vedolizumab is associated with UC severity, lower serum vedolizumab levels and rates of clinical response: Results from the FAVOUR studyMark A Samaan, Georgina Cunningham, Samuel Hsiang Lim, et al.Chemical Communications (Cambridge, England)|December 21, 2022
Formation of a meltable purinate metal-organic framework and its glass analogueAlice M Bumstead, Celia Castillo-Blas, Ignas Pakamorė, et al.Journal of Crohn'S & Colitis|April 14, 2020
Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK ExperienceSailish Honap, Desmond Chee, Thomas P Chapman, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2019
Genetic and Inflammatory Biomarkers Classify Small Intestine Inflammation in Asymptomatic First-degree Relatives of Patients With Crohn's DiseaseKirstin M Taylor, Ken B Hanscombe, Natalie J Prescott, et al.Inflammatory Bowel Diseases|February 17, 2012
Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groupsA S Cheifetz, G Y Melmed, B Spiegel, et al.Nature|August 10, 1999
Dynamic measurement of myosin light-chain-domain tilt and twist in muscle contractionJ E Corrie, B D Brandmeier, R E Ferguson, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 6, 2018
Appropriateness of Combination Therapy for Patients With Inflammatory Bowel Diseases: One Size Still Does Not Fit AllGil Y Melmed, Gilaad G Kaplan, Miles P Sparrow, et al.Gastroenterology|February 3, 2019
Correction of Defective T-Regulatory Cells From Patients With Crohn's Disease by Ex Vivo Ligation of Retinoic Acid Receptor-αRimma Goldberg, Cristiano Scotta, Dianne Cooper, et al.Digestive Diseases and Sciences|January 27, 2025
Anti-tumor Necrosis Factor Drug Concentration Is Not Associated with Disease Outcomes in Pouchitis: A Retrospective, International StudySailish Honap, Bénédicte Caron, Jacob E Ollech, et al.The American Journal of Gastroenterology|July 15, 2024
When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel DiseaseHannah K Systrom, Victoria Rai, Siddharth Singh, et al.Pageof 52